SlideShare a Scribd company logo
Esophageal Stent
Dr. Yash Kumar Achantani
OSR
Definition
Stents are devices used to maintain or restore
the lumen of hollow organs, vessels, and ducts.
History
• Invented in 1856 by the English dentist
Charles Stent .
• The first (self expanding) "stents" used in
medical practice in 1986 by Ulrich Sigwart in
Lausanne were initially called "Wallstents".
• Julio Palmaz et al. created a balloon
expandable stent that is currently used.
• Sir Charters Symonds was the first to successfully
place an oesophageal prosthesis across a
malignant stricture.
• There were many modifications of rigid
oesophageal stents in which various materials
(wood, metal, plastic, latex) and designs were
used.
• The rigid prosthesis (plastic and latex) was
extensively used from the 1970s to the 1990s,
but the complication rates and mortality
associated with insertion-related perforations
remained significant.
• In the early 1990s, self-expandable metal
stents (SEMS) were developed for
oesophageal use.
Types of Esophageal Stents
1. SEPS (self-expanding plastic stents)
2. SEMS (self-expanding metal stents)
3. Biodegradable stents
SEPS
• SEPS (Polyflex; Boston Scientific, Natick, Mass)
has been developed for esophageal strictures.
• This stent has a woven polyester skeleton and
is completely covered with a silicone
membrane.
• The silicone prevents tissue in growth through
the mesh.
• Polyester braids on the external surface
anchor the stent to the mucosa to limit
migration.
SEMS
• There are three varieties of metal stents:
uncovered, partially covered, and fully
covered.
• The advantage of covered stents is that they
resist tumour ingrowth, but they have a higher
migration rate, especially when fully covered
but have advantage of potentially being
removable.
• Partially covered stents are uncovered at their
ends, which allows the stent to embed in the
tissue and helps to prevent migration.
• Uncovered stents are less likely to migrate, but
are subject to tumour ingrowth and resultant
obstruction.
• SEMS consist of woven, knitted, or laser-cut
metal mesh cylinders that exert self-expansive
forces until they reach their maximum fixed
diameter.
• SEMS are composed of stainless steel, alloys
such as elgiloy and nitinol, or a combination of
nitinol and silicone.
• Elgiloy, an alloy composed primarily of cobalt,
nickel, and chromium, is corrosion resistant
and capable of generating high radial forces.
• Nitinol, an alloy of nickel and titanium, yields
increased flexibility that is helpful for stenting
sharply angulated regions at the cost of lesser
radial force.
• To prevent tumour ingrowth, the interstices
between the metal mesh of oesophageal
SEMSs may be wholly or partially covered by a
plastic membrane or silicone.
• For tumours located near the GE junction
(Oesophageal Z-stent with Dual Anti-reflux
valve; Wilson-Cook Medical, Winston-Salem,
NC) uses an extended polyurethane
membrane 8 cm beyond the metal portion of
the stent to prevent gastroesophageal reflux.
Biodegradable stents
• Oesophageal Degradable BD (Ella-CS, Czech
Republic) is made from woven surgical suture
material, polydioxanone.
• It is uncovered and does not have an anti-
reflux valve.
• The stent fully degrades in approximately
three months
Photograph shows
Atkinson (A) and
Celestin (B) plastic
stents and
Wilson-Cook (C)
Ultraflex nitinol (D),
Wallstent (E),
Gianturco Z (F), and
Esophacoil (G) metal
stents.
Esophageal stent
From left to right,
Boston Scientific’s
Polyflex
Esophageal Stent,
Ultraflex
Esophageal NG
Stent System,
WallFlex Fully
Covered
Esophageal Stent,
and WallFlex
Partially Covered
Esophageal Stent.
Esophageal stent
Esophageal stent
Indications
• Dysphagia from oesophageal malignancy.
• Benign oesophageal strictures (peptic,
radiation induced, anastomotic, and caustic).
• Postoperative leaks.
• Iatrogenic perforations.
• External compression from extraoesophageal
tumours.
• Tracheoesophageal fistulas.
• Achalasia cardia.
• Bleeding varices.
Technique
• Assessment of the length of the stricture and
degree of obstruction is the first step.
• If the stricture is too tight to advance a
standard gastroscope, an ultrathin endoscope
may be used.
• To guide accurate stent deployment, the
proximal and distal ends of the stricture need
to be marked appropriately.
• During stent selection, it is important to
choose a stent length that is 4 cm longer than
the stricture being stented.
• This allows for 2 cm of stent on either end of
the stricture to decrease the risk of migration.
• Foreshortening is the property of the stent by
which, on fluoroscopy, the stent constrained
in its catheter will appear longer than the
unconstrained deployed stent length.
• Stenting a stricture in the cervical oesophagus
ensure at least a 2-cm distance between the
proximal end of the stent and the upper
oesophageal sphincter.
Barium swallow shows a short
stricture in the mid oesophagus.
Biopsy showed squamous cell
carcinoma.
A guide wire and catheter
combination has been passed
down through the stricture and a
small amount of contrast injected
at the proximal and distal margins
of the tumour.
Paper clips have been taped to the
patient’s skin to indicate the
stricture length.
The stent deployment system has
been passed across the stricture.
Note in this example the markers
on the proximal and distal ends of
the stent and also in the centre of
the stent. The stent should be
placed so that the proximal and
distal ends are 2 cm beyond the
stricture.
The stent has been
released.
Note the immediate
expansion of the proximal
and distal ends, while the
central area is still
constrained by the tumor.
The delivery system has been
removed. The stent expanded
fully over the next 48 hours
without further dilatation.
Esophacoil. Barium
esophagogram (lateral
projection) shows a
normally
placed, normally
functioning Esophacoil.
Distal oesophageal covered stent traversing the
GOJ.
Distal oesophageal
covered stent
traversing the GOJ.
Oesophageal stent is noted in the midpart of the
thoracic oesophagus
Complications
Complications associated with oesophageal
stents are generally classified as either early or
delayed.
Early complications- 2-4 weeks
• Chest pain, fever, bleeding, gastroesophageal
reflux disease, globus sensation, perforation,
and stent migration
Delayed complications- after 4 weeks
• Tumour ingrowth, stent migration, stent
occlusion, development of oesophageal
fistulae, and recurrence of strictures.
Perforation. Barium
esophagogram shows a
Celestin tube placed across
the oesophagogastric
junction. There is
extravasation of barium into
the left pleural space and
mediastinum due to
perforation.
Tumour ingrowth.
Barium esophagogram
shows an uncoated
Ultraflex nitinol
stent with an irregular
inner contour due to
tumour growth through
the metallie mesh.
Combined overgrowth and
ingrowth through an uncovered
stent.
Challenges in Oesophageal Stent
Placement
High-Grade Strictures
• If a stricture is very tight or difficult to traverse
with a standard endoscope.
• One option is to use a dilator(Mercury or
tungsten-weighted bougies, Polyvinyl dilators
& Through-the-scope (TTS) balloon dilators).
• Another method involves using a stent with a
smaller diameter.
Upper Oesophageal and Cervical Oesophageal
Strictures
• Traditionally, strictures close to the upper
oesophageal sphincter (UES) have been
considered more difficult to manage.
• However, studies have recently demonstrated the
effectiveness and safety of newer stents for the
palliation of dysphagia and sealing of fistulae in
patients with strictures close to the UES.
Distal Oesophageal Strictures,
Gastroesophageal Cancers, and Cardia Cancers
• Distal oesophageal strictures still present a
significant challenge because stent placement
across the gastroesophageal junction can lead
to gastroesophageal reflux disease and
aspiration.
• In an attempt to remedy these problems,
stents with antireflux mechanisms have been
developed (Esophageal Z-Stent with Dua Anti-
Reflux Valve)
Management of Benign Oesophageal
Conditions
• The use of self-expandable oesophageal stents
for the management of benign conditions has
grown immensely over the past decade.
• Temporary placement of self-expandable stents is
now used in a variety of benign conditions,
including postoperative anastomotic leaks,
refractory strictures due to peptic ulcers or
radiation, and tracheoesophageal fistulae.
• SEPS are increasingly being used for the
treatment of benign oesophageal conditions.
• These stents are thought to have several
advantages over standard SEMS—including
low cost, ease of placement and retrieval, and
limited local tissue reaction—and still provide
symptomatic relief of dysphagia
Management of Malignant
Oesophageal Diseases
• Despite advances in the diagnosis, staging,
neoadjuvant care, and perioperative care of
patients with oesophageal cancer, the 5-year
survival rate of these patients remains less than
15%, and chemotherapy has shown limited
survival benefit.
• Therefore, patients with incurable oesophageal
and other nonluminal malignancies of the head
and neck often require palliation for dysphagia
and/or tracheoesophageal fistulae.
• Currently, SEMS, along with SEPS, have
become the mainstay of treatment for
malignant oesophageal strictures and fistulae.
• Covered stents are commonly used as they
resist tumour ingrowth because they do not
have an uncovered region that embeds into
tissue they also offer the advantage of being
completely removable.
• Use of SEMS for treating cancer closer to the
UES is controversial because of the perceived
increased risk of complications such as
perforation, migration, pain, and patient
intolerance.
Esophageal stent

More Related Content

What's hot (20)

Ln in ca penis by Praveen Ganji, has 30 slides with 3655 views.
Ln in ca penisLn in ca penis
Ln in ca penis
Praveen Ganji
30 slides3.7K views
LAP ANTERIOR RESECTION-STEP BY STEP Operative Surgery.pptx by Selvaraj Balasubramani, has 18 slides with 6433 views.
LAP ANTERIOR RESECTION-STEP BY STEP Operative Surgery.pptxLAP ANTERIOR RESECTION-STEP BY STEP Operative Surgery.pptx
LAP ANTERIOR RESECTION-STEP BY STEP Operative Surgery.pptx
Selvaraj Balasubramani
18 slides6.4K views
Bile duct injuries.slideshare by drksreenath, has 41 slides with 19544 views.
Bile duct injuries.slideshareBile duct injuries.slideshare
Bile duct injuries.slideshare
drksreenath
41 slides19.5K views
ACHALASIA CARDIA: ENDOSCOPIC THERAPY (POEM) by Dr Amit Dangi, has 18 slides with 1687 views.
ACHALASIA CARDIA: ENDOSCOPIC THERAPY (POEM)ACHALASIA CARDIA: ENDOSCOPIC THERAPY (POEM)
ACHALASIA CARDIA: ENDOSCOPIC THERAPY (POEM)
Dr Amit Dangi
18 slides1.7K views
Natural Orifice Transluminal Endoscopic Surgery"NOTES" by Hisham Ahmed,M.D,PhD,MRCS, has 25 slides with 10897 views.
Natural Orifice Transluminal Endoscopic Surgery"NOTES"Natural Orifice Transluminal Endoscopic Surgery"NOTES"
Natural Orifice Transluminal Endoscopic Surgery"NOTES"
Hisham Ahmed,M.D,PhD,MRCS
25 slides10.9K views
Pancreatic Cancer.pptx by Kiran Ramakrishna, has 54 slides with 8419 views.
Pancreatic Cancer.pptxPancreatic Cancer.pptx
Pancreatic Cancer.pptx
Kiran Ramakrishna
54 slides8.4K views
Liver resection indications & methods by Dr Harsh Shah, has 103 slides with 11596 views.
Liver resection   indications & methodsLiver resection   indications & methods
Liver resection indications & methods
Dr Harsh Shah
103 slides11.6K views
Types of mesh & complications by chirag Krishna Yadav, has 55 slides with 18114 views.
Types of mesh & complicationsTypes of mesh & complications
Types of mesh & complications
chirag Krishna Yadav
55 slides18.1K views

Similar to Esophageal stent (20)

Types of intestinal stomas and management by Ankita Singh, has 64 slides with 6546 views.
Types of intestinal stomas and management Types of intestinal stomas and management
Types of intestinal stomas and management
Ankita Singh
64 slides6.5K views
Upper urinary tract drainage by SRIKANTH VALASAPALLI, has 64 slides with 615 views.
Upper urinary tract drainageUpper urinary tract drainage
Upper urinary tract drainage
SRIKANTH VALASAPALLI
64 slides615 views
percutaneous non vascular GI Interventions.pptx by deepashreeselvakumar, has 39 slides with 21 views.
percutaneous non vascular GI Interventions.pptxpercutaneous non vascular GI Interventions.pptx
percutaneous non vascular GI Interventions.pptx
deepashreeselvakumar
39 slides21 views
Vaginal approach for Stress Urinary Incontinence surgery by Rohan Sharma, has 94 slides with 340 views.
Vaginal approach for Stress Urinary Incontinence surgeryVaginal approach for Stress Urinary Incontinence surgery
Vaginal approach for Stress Urinary Incontinence surgery
Rohan Sharma
94 slides340 views
Git j club dysphagia endoscopy. by Shaikhani., has 54 slides with 2345 views.
Git j club dysphagia endoscopy.Git j club dysphagia endoscopy.
Git j club dysphagia endoscopy.
Shaikhani.
54 slides2.3K views
Resection & anastomosis of boweL its complications PRANAYA PPT by PRANAYA PANIGRAHI, has 104 slides with 12063 views.
Resection & anastomosis of boweL its complications PRANAYA PPTResection & anastomosis of boweL its complications PRANAYA PPT
Resection & anastomosis of boweL its complications PRANAYA PPT
PRANAYA PANIGRAHI
104 slides12.1K views
Principles of Bowel Anastomosis (s&l)-1.pptx by sharifgbadamosi, has 42 slides with 427 views.
Principles of Bowel Anastomosis (s&l)-1.pptxPrinciples of Bowel Anastomosis (s&l)-1.pptx
Principles of Bowel Anastomosis (s&l)-1.pptx
sharifgbadamosi
42 slides427 views

Slideshows for you (20)

Culture
CultureCulture
Culture
Reed Hastings
 
People Don't Care About Your Brand
People Don't Care About Your BrandPeople Don't Care About Your Brand
People Don't Care About Your Brand
Slides That Rock
 
Working With Big Data
Working With Big DataWorking With Big Data
Working With Big Data
Seth Familian
 
Unconscious Bias: From Awareness to Action (.ppt)
Unconscious Bias: From Awareness to Action (.ppt)Unconscious Bias: From Awareness to Action (.ppt)
Unconscious Bias: From Awareness to Action (.ppt)
Rotary International
 
MyMedRecs NYU Final Presentation
MyMedRecs NYU Final PresentationMyMedRecs NYU Final Presentation
MyMedRecs NYU Final Presentation
Stanford University
 
What is Product Management?
What is Product Management?What is Product Management?
What is Product Management?
Brainmates Pty Limited
 
How to Craft Your Company's Storytelling Voice by Ann Handley of MarketingProfs
How to Craft Your Company's Storytelling Voice by Ann Handley of MarketingProfsHow to Craft Your Company's Storytelling Voice by Ann Handley of MarketingProfs
How to Craft Your Company's Storytelling Voice by Ann Handley of MarketingProfs
MarketingProfs
 
Innovation Games™
Innovation Games™Innovation Games™
Innovation Games™
Michael Tarnowski
 
People Don't Care About Your Brand
People Don't Care About Your BrandPeople Don't Care About Your Brand
People Don't Care About Your Brand
Slides That Rock
 
Working With Big Data
Working With Big DataWorking With Big Data
Working With Big Data
Seth Familian
 
Unconscious Bias: From Awareness to Action (.ppt)
Unconscious Bias: From Awareness to Action (.ppt)Unconscious Bias: From Awareness to Action (.ppt)
Unconscious Bias: From Awareness to Action (.ppt)
Rotary International
 
MyMedRecs NYU Final Presentation
MyMedRecs NYU Final PresentationMyMedRecs NYU Final Presentation
MyMedRecs NYU Final Presentation
Stanford University
 
How to Craft Your Company's Storytelling Voice by Ann Handley of MarketingProfs
How to Craft Your Company's Storytelling Voice by Ann Handley of MarketingProfsHow to Craft Your Company's Storytelling Voice by Ann Handley of MarketingProfs
How to Craft Your Company's Storytelling Voice by Ann Handley of MarketingProfs
MarketingProfs
 

More from Dr. Yash Kumar Achantani (20)

USG of Aorta and Coeliac axis by Dr. Yash Kumar Achantani, has 60 slides with 2751 views.
USG of Aorta and Coeliac axisUSG of Aorta and Coeliac axis
USG of Aorta and Coeliac axis
Dr. Yash Kumar Achantani
60 slides2.8K views
TACE- Transarterial Chemoembolisation by Dr. Yash Kumar Achantani, has 19 slides with 8096 views.
TACE- Transarterial Chemoembolisation TACE- Transarterial Chemoembolisation
TACE- Transarterial Chemoembolisation
Dr. Yash Kumar Achantani
19 slides8.1K views
Retrograde Pyelography by Dr. Yash Kumar Achantani, has 23 slides with 11758 views.
Retrograde PyelographyRetrograde Pyelography
Retrograde Pyelography
Dr. Yash Kumar Achantani
23 slides11.8K views
Imaging of Renal Tumors by Dr. Yash Kumar Achantani, has 100 slides with 3560 views.
Imaging of Renal TumorsImaging of Renal Tumors
Imaging of Renal Tumors
Dr. Yash Kumar Achantani
100 slides3.6K views
Renal isotope scan by Dr. Yash Kumar Achantani, has 38 slides with 4537 views.
Renal isotope scanRenal isotope scan
Renal isotope scan
Dr. Yash Kumar Achantani
38 slides4.5K views
Post Processing of CT Thorax by Dr. Yash Kumar Achantani, has 23 slides with 3138 views.
Post Processing of CT ThoraxPost Processing of CT Thorax
Post Processing of CT Thorax
Dr. Yash Kumar Achantani
23 slides3.1K views
Imaging of Obstructive jaundice by Dr. Yash Kumar Achantani, has 101 slides with 12665 views.
Imaging of Obstructive jaundiceImaging of Obstructive jaundice
Imaging of Obstructive jaundice
Dr. Yash Kumar Achantani
101 slides12.7K views
HIDA Scan by Dr. Yash Kumar Achantani, has 66 slides with 16325 views.
HIDA ScanHIDA Scan
HIDA Scan
Dr. Yash Kumar Achantani
66 slides16.3K views

Recently uploaded (20)

India Quiz- 26 January 2025, Quiz Club NITW by Quiz Club NITW, has 177 slides with 611 views.
India Quiz- 26 January 2025, Quiz Club NITWIndia Quiz- 26 January 2025, Quiz Club NITW
India Quiz- 26 January 2025, Quiz Club NITW
Quiz Club NITW
177 slides611 views
Digital Marketing Workshop Overview | Leadzap | Rishabh Mehta by rishabhmehta66919, has 8 slides with 322 views.
Digital Marketing Workshop Overview | Leadzap | Rishabh MehtaDigital Marketing Workshop Overview | Leadzap | Rishabh Mehta
Digital Marketing Workshop Overview | Leadzap | Rishabh Mehta
rishabhmehta66919
8 slides322 views
Antimalarials- History, Classification, SAR and Mechanism of action by GirishKashid, has 49 slides with 68 views.
Antimalarials- History, Classification, SAR and Mechanism of actionAntimalarials- History, Classification, SAR and Mechanism of action
Antimalarials- History, Classification, SAR and Mechanism of action
GirishKashid
49 slides68 views
BRMK557 Model Question Paper – 1 Solution.pdf by VishalMore197390, has 50 slides with 2182 views.
BRMK557 Model Question Paper – 1 Solution.pdfBRMK557 Model Question Paper – 1 Solution.pdf
BRMK557 Model Question Paper – 1 Solution.pdf
VishalMore197390
50 slides2.2K views
"I’m Excited About Writing a Computer Policy” — Said Nobody Ever.pdf by TechSoup , has 32 slides with 53 views.
"I’m Excited About Writing a Computer Policy” — Said Nobody Ever.pdf"I’m Excited About Writing a Computer Policy” — Said Nobody Ever.pdf
"I’m Excited About Writing a Computer Policy” — Said Nobody Ever.pdf
TechSoup
32 slides53 views
SCIENCE 7 Quarter 3 lesson matatag curriculum by KeithLabustro, has 29 slides with 154 views.
SCIENCE 7 Quarter 3 lesson matatag curriculumSCIENCE 7 Quarter 3 lesson matatag curriculum
SCIENCE 7 Quarter 3 lesson matatag curriculum
KeithLabustro
29 slides154 views
Notes on DeepSeek as of 29th of January 2025 by Damian T. Gordon, has 28 slides with 496 views.
Notes on DeepSeek as of 29th of January 2025Notes on DeepSeek as of 29th of January 2025
Notes on DeepSeek as of 29th of January 2025
Damian T. Gordon
28 slides496 views
Antimalarials- History, Classification, SAR and Mechanism of action by GirishKashid, has 49 slides with 68 views.
Antimalarials- History, Classification, SAR and Mechanism of actionAntimalarials- History, Classification, SAR and Mechanism of action
Antimalarials- History, Classification, SAR and Mechanism of action
GirishKashid
49 slides68 views
"I’m Excited About Writing a Computer Policy” — Said Nobody Ever.pdf by TechSoup , has 32 slides with 53 views.
"I’m Excited About Writing a Computer Policy” — Said Nobody Ever.pdf"I’m Excited About Writing a Computer Policy” — Said Nobody Ever.pdf
"I’m Excited About Writing a Computer Policy” — Said Nobody Ever.pdf
TechSoup
32 slides53 views

Esophageal stent

  • 1. Esophageal Stent Dr. Yash Kumar Achantani OSR
  • 2. Definition Stents are devices used to maintain or restore the lumen of hollow organs, vessels, and ducts.
  • 3. History • Invented in 1856 by the English dentist Charles Stent . • The first (self expanding) "stents" used in medical practice in 1986 by Ulrich Sigwart in Lausanne were initially called "Wallstents". • Julio Palmaz et al. created a balloon expandable stent that is currently used.
  • 4. • Sir Charters Symonds was the first to successfully place an oesophageal prosthesis across a malignant stricture. • There were many modifications of rigid oesophageal stents in which various materials (wood, metal, plastic, latex) and designs were used. • The rigid prosthesis (plastic and latex) was extensively used from the 1970s to the 1990s, but the complication rates and mortality associated with insertion-related perforations remained significant.
  • 5. • In the early 1990s, self-expandable metal stents (SEMS) were developed for oesophageal use.
  • 6. Types of Esophageal Stents 1. SEPS (self-expanding plastic stents) 2. SEMS (self-expanding metal stents) 3. Biodegradable stents
  • 7. SEPS • SEPS (Polyflex; Boston Scientific, Natick, Mass) has been developed for esophageal strictures. • This stent has a woven polyester skeleton and is completely covered with a silicone membrane.
  • 8. • The silicone prevents tissue in growth through the mesh. • Polyester braids on the external surface anchor the stent to the mucosa to limit migration.
  • 9. SEMS • There are three varieties of metal stents: uncovered, partially covered, and fully covered. • The advantage of covered stents is that they resist tumour ingrowth, but they have a higher migration rate, especially when fully covered but have advantage of potentially being removable.
  • 10. • Partially covered stents are uncovered at their ends, which allows the stent to embed in the tissue and helps to prevent migration. • Uncovered stents are less likely to migrate, but are subject to tumour ingrowth and resultant obstruction. • SEMS consist of woven, knitted, or laser-cut metal mesh cylinders that exert self-expansive forces until they reach their maximum fixed diameter.
  • 11. • SEMS are composed of stainless steel, alloys such as elgiloy and nitinol, or a combination of nitinol and silicone. • Elgiloy, an alloy composed primarily of cobalt, nickel, and chromium, is corrosion resistant and capable of generating high radial forces. • Nitinol, an alloy of nickel and titanium, yields increased flexibility that is helpful for stenting sharply angulated regions at the cost of lesser radial force.
  • 12. • To prevent tumour ingrowth, the interstices between the metal mesh of oesophageal SEMSs may be wholly or partially covered by a plastic membrane or silicone. • For tumours located near the GE junction (Oesophageal Z-stent with Dual Anti-reflux valve; Wilson-Cook Medical, Winston-Salem, NC) uses an extended polyurethane membrane 8 cm beyond the metal portion of the stent to prevent gastroesophageal reflux.
  • 13. Biodegradable stents • Oesophageal Degradable BD (Ella-CS, Czech Republic) is made from woven surgical suture material, polydioxanone. • It is uncovered and does not have an anti- reflux valve. • The stent fully degrades in approximately three months
  • 14. Photograph shows Atkinson (A) and Celestin (B) plastic stents and Wilson-Cook (C) Ultraflex nitinol (D), Wallstent (E), Gianturco Z (F), and Esophacoil (G) metal stents.
  • 16. From left to right, Boston Scientific’s Polyflex Esophageal Stent, Ultraflex Esophageal NG Stent System, WallFlex Fully Covered Esophageal Stent, and WallFlex Partially Covered Esophageal Stent.
  • 19. Indications • Dysphagia from oesophageal malignancy. • Benign oesophageal strictures (peptic, radiation induced, anastomotic, and caustic). • Postoperative leaks. • Iatrogenic perforations.
  • 20. • External compression from extraoesophageal tumours. • Tracheoesophageal fistulas. • Achalasia cardia. • Bleeding varices.
  • 21. Technique • Assessment of the length of the stricture and degree of obstruction is the first step. • If the stricture is too tight to advance a standard gastroscope, an ultrathin endoscope may be used. • To guide accurate stent deployment, the proximal and distal ends of the stricture need to be marked appropriately.
  • 22. • During stent selection, it is important to choose a stent length that is 4 cm longer than the stricture being stented. • This allows for 2 cm of stent on either end of the stricture to decrease the risk of migration. • Foreshortening is the property of the stent by which, on fluoroscopy, the stent constrained in its catheter will appear longer than the unconstrained deployed stent length.
  • 23. • Stenting a stricture in the cervical oesophagus ensure at least a 2-cm distance between the proximal end of the stent and the upper oesophageal sphincter.
  • 24. Barium swallow shows a short stricture in the mid oesophagus. Biopsy showed squamous cell carcinoma.
  • 25. A guide wire and catheter combination has been passed down through the stricture and a small amount of contrast injected at the proximal and distal margins of the tumour. Paper clips have been taped to the patient’s skin to indicate the stricture length.
  • 26. The stent deployment system has been passed across the stricture. Note in this example the markers on the proximal and distal ends of the stent and also in the centre of the stent. The stent should be placed so that the proximal and distal ends are 2 cm beyond the stricture.
  • 27. The stent has been released. Note the immediate expansion of the proximal and distal ends, while the central area is still constrained by the tumor.
  • 28. The delivery system has been removed. The stent expanded fully over the next 48 hours without further dilatation.
  • 29. Esophacoil. Barium esophagogram (lateral projection) shows a normally placed, normally functioning Esophacoil.
  • 30. Distal oesophageal covered stent traversing the GOJ.
  • 31. Distal oesophageal covered stent traversing the GOJ.
  • 32. Oesophageal stent is noted in the midpart of the thoracic oesophagus
  • 33. Complications Complications associated with oesophageal stents are generally classified as either early or delayed. Early complications- 2-4 weeks • Chest pain, fever, bleeding, gastroesophageal reflux disease, globus sensation, perforation, and stent migration
  • 34. Delayed complications- after 4 weeks • Tumour ingrowth, stent migration, stent occlusion, development of oesophageal fistulae, and recurrence of strictures.
  • 35. Perforation. Barium esophagogram shows a Celestin tube placed across the oesophagogastric junction. There is extravasation of barium into the left pleural space and mediastinum due to perforation.
  • 36. Tumour ingrowth. Barium esophagogram shows an uncoated Ultraflex nitinol stent with an irregular inner contour due to tumour growth through the metallie mesh.
  • 37. Combined overgrowth and ingrowth through an uncovered stent.
  • 38. Challenges in Oesophageal Stent Placement High-Grade Strictures • If a stricture is very tight or difficult to traverse with a standard endoscope. • One option is to use a dilator(Mercury or tungsten-weighted bougies, Polyvinyl dilators & Through-the-scope (TTS) balloon dilators). • Another method involves using a stent with a smaller diameter.
  • 39. Upper Oesophageal and Cervical Oesophageal Strictures • Traditionally, strictures close to the upper oesophageal sphincter (UES) have been considered more difficult to manage. • However, studies have recently demonstrated the effectiveness and safety of newer stents for the palliation of dysphagia and sealing of fistulae in patients with strictures close to the UES.
  • 40. Distal Oesophageal Strictures, Gastroesophageal Cancers, and Cardia Cancers • Distal oesophageal strictures still present a significant challenge because stent placement across the gastroesophageal junction can lead to gastroesophageal reflux disease and aspiration. • In an attempt to remedy these problems, stents with antireflux mechanisms have been developed (Esophageal Z-Stent with Dua Anti- Reflux Valve)
  • 41. Management of Benign Oesophageal Conditions • The use of self-expandable oesophageal stents for the management of benign conditions has grown immensely over the past decade. • Temporary placement of self-expandable stents is now used in a variety of benign conditions, including postoperative anastomotic leaks, refractory strictures due to peptic ulcers or radiation, and tracheoesophageal fistulae.
  • 42. • SEPS are increasingly being used for the treatment of benign oesophageal conditions. • These stents are thought to have several advantages over standard SEMS—including low cost, ease of placement and retrieval, and limited local tissue reaction—and still provide symptomatic relief of dysphagia
  • 43. Management of Malignant Oesophageal Diseases • Despite advances in the diagnosis, staging, neoadjuvant care, and perioperative care of patients with oesophageal cancer, the 5-year survival rate of these patients remains less than 15%, and chemotherapy has shown limited survival benefit. • Therefore, patients with incurable oesophageal and other nonluminal malignancies of the head and neck often require palliation for dysphagia and/or tracheoesophageal fistulae.
  • 44. • Currently, SEMS, along with SEPS, have become the mainstay of treatment for malignant oesophageal strictures and fistulae. • Covered stents are commonly used as they resist tumour ingrowth because they do not have an uncovered region that embeds into tissue they also offer the advantage of being completely removable.
  • 45. • Use of SEMS for treating cancer closer to the UES is controversial because of the perceived increased risk of complications such as perforation, migration, pain, and patient intolerance.